User:Mr. Ibrahem/Methoxy polyethylene glycol-epoetin beta

Methoxy polyethylene glycol-epoetin beta, sold under the brand name Mircera, is a medication used to treat low red blood cells due to chronic kidney disease. It is given by injection. Hemoglobin levels should not be increased above 110 g/L (11 g/dL).

Common side effects include high blood pressure and diarrhea. Other side effects may include erythema multiforme, anaphylaxis, seizures, and worsened outcomes in people with cancer. It is an erythropoiesis-stimulating agent (ESA) and works the same as erythropoietin.

Methoxy polyethylene glycol-epoetin beta was approved for medical use in the United States and Europe in 2007. It is on the World Health Organization's List of Essential Medicines. In the United Kingdom 75 micrograms costs the NHS about £110 as of 2021. This amount in the United States is about 220 USD.